Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;18(9):26-42F.

Antidepressants for Pediatric Patients

Jennifer B Dwyer  1 , Michael H Bloch  2
Affiliations

Antidepressants for Pediatric Patients

Jennifer B Dwyer et al. Curr Psychiatr. 2019 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cates plot depicting the benefits of antidepressants vs risk of suicidal ideation for pediatric patients with anxiety disorders
Green faces: Children who will respond to both placebo and antidepressant Yellow faces: Children who respond to antidepressants but not placebo White faces: Nonresponders to both medication and placebo Red faces: Children who will experience suicidal ideation on medication but not placebo Faces covered with an X: Children who will complete suicide on medication but not placebo Note: There are no faces with Xs because there were no suicides in randomized controlled trials Source: Based on data from reference
Figure 2
Figure 2. Cates plot depicting the benefits of antidepressants vs risk of suicidal ideation for pediatric patients with major depressive disorder
Green faces: Children who will respond to both placebo and antidepressant Yellow faces: Children who respond to antidepressants but not placebo White faces: Nonresponders to both medication and placebo Gray faces: Children who will experience suicidal ideation on both medication and placebo Red faces: Children who will experience suicidal ideation on medication but not placebo Faces covered with an X: Children who will complete suicide on medication but not placebo Note: There are no faces with Xs because there were no suicides in randomized controlled trials Source: Based on data from reference
Figure 3
Figure 3. Cates plot depicting the benefits of antidepressants vs risk of suicidal ideation for pediatric patients with obsessive-compulsive disorder
Green faces: Children who will respond to both placebo and antidepressant Yellow faces: Children who respond to antidepressants but not placebo White faces: Nonresponders to both medication and placebo Gray faces: Children who will experience suicidal ideation on both medication and placebo Red faces: Children who will experience suicidal ideation on medication but not placebo Faces covered with an X: Children who will complete suicide on medication but not placebo Note: There are no faces with Xs because there were no suicides in randomized controlled trials Source: Based on data from reference
See this image and copyright information in PMC

References

    1. Williams SB, O’Connor EA, Eder M, et al. Screening for child and adolescent depression in primary care settings: a systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2009;123(4):e716–e735. doi: 10.1542/peds.2008-2415. - DOI - PubMed
    1. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry. 2001;49(12):1002–1014. - PubMed
    1. Lewinsohn PM, Clarke GN, Seeley JR, et al. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994;33(6):809–818. - PubMed
    1. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA.1999;281(18):1707–1713. - PubMed
    1. Fergusson DM, Woodward LJ. Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry. 2002;59(3):225–231. - PubMed

LinkOut - more resources